Anheuser-Busch InBev S.A. ADR (BUD) News
Filter BUD News Items
BUD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BUD News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BUD News From Around the Web
Below are the latest news stories about ANHEUSER-BUSCH INBEV SA that investors may wish to consider to help them evaluate BUD as an investment opportunity.
Anheuser-Busch InBev SA/NV (BUD): Short Seller Sentiment is BullishWe recently compiled a list of the 10 Best Liquor Stocks To Buy According to Short Sellers. In this article, we are going to take a look at where Anheuser-Busch InBev SA/NV (NYSE:BUD) stands against the other liquor stocks. Short selling is a strategy where traders profit from the decline in the price of a stock […] |
AB InBev Set to Brew Pabst Beer: What Does it Mean for BUD Stock?AB InBev partners to brew beer for Pabst in its breweries. This marks a significant step for AB InBev to integrate a former competitor into its supply chain. |
AB InBev price target lowered to EUR 66 from EUR 70 at UBSUBS analyst Sanjeet Aujla lowered the firm’s price target on AB InBev (BUD) to EUR 66 from EUR 70 and keeps a Buy rating on the shares as part of a Q4 earnings preview. The company’s volumes are still weak, but its leverage and free cash flow will “positively inflect,” the analyst tells investors in a research note. The firm believes AB InBev’s deleveraging and free cash flow upside is on track despite a soft volume quarter. Published first on TheFly – the ultimate source for real-time, market-m |
Anheuser-Busch to Make Pabst Beer After Molson Coors Partnership EndsThe deal moves a former rival into AB InBev's supply chain. |
Update: Alcohol Beverage Stocks Fall After US Surgeon General Calls for Cancer Warnings on Alcoholic Drinks(Updates with statement from a spokesperson at the Beer Institute in the fifth paragraph.) Shares |
AB InBev's Stock Dips Further: Cancer Warning Labels Recommended for Alcohol BeveragesAB InBev and Other Major Alcohol Companies See Significant Declines Following Health Advisory |
Alcohol brands startled by Surgeon General's cancer risk advisoryShares of alcohol producers like Anheuser-Busch InBev (BUD), Molson Coors (TAP), and Constellation Brands (STZ) took a slight spill in Friday's session after the US Surgeon General Dr. Vivek Murthy issued an advisory on the link between alcohol and cancer. Yahoo Finance senior retail reporter Brooke DiPalma joins Josh Lipton on Asking for a Trend to discuss the Surgeon General's call to add cancer warning labels on alcoholic drinks and beverages, outlining a number of other headwinds the industry could face stemming from this. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Luke Carberry Mogan. |
Bud and Molson Stock Fall as Surgeon General Warns of Beer and Wine’s Cancer LinkU.S. Surgeon General Vivek Murthy issues an advisory outlining the link between alcohol consumption and cancer risk. |
Beer and alcohol stocks face bigger challenges as US surgeon general links drinking to cancer riskSurgeon General Vivek Murthy's link of alcohol to cancer risks spills over into Friday's trading session. |
Alcohol stocks slip after US Surgeon General's call for warning labelAlcohol brands Anheuser-Busch InBev (BUD), Molson Coors (TAP), and Constellation Brands (STZ) are seeing their share prices slip Friday morning after the US Surgeon General Dr. Vivek Murthy issued an advisory to add cancer warning labels on alcoholic drinks and beverages. Yahoo Finance senior health reporter Anjalee Khemlani breaks down the US Surgeon General's call to raise awareness around alcohol-related cancers. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan. |